Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease

Trends Endocrinol Metab. 2018 Oct;29(10):712-722. doi: 10.1016/j.tem.2018.08.003. Epub 2018 Aug 18.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the most epidemic liver disease worldwide owing to rapid changes in lifestyle over the past few decades. This chronic condition intertwines with low-grade inflammation and metabolic disequilibrium, and potentiates the onset and progression of devastating hepatic and extrahepatic complications. In addition to an integral role in promoting host defense, recent studies also implicate innate immune signaling in a multitude of processes that control the progression of NAFLD. The focus of this review is to highlight emerging evidence regarding the role of innate immunity in NAFLD and the integration of different pathways that affect both inflammation and metabolism across the spectrum of this liver morbidity.

Keywords: adaptor proteins; innate immunity; kinases; nonalcoholic fatty liver disease (NAFLD); nuclear transcription factors; pattern recognition receptors (PRRs).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Immunity, Innate / immunology*
  • Inflammation / immunology*
  • Inflammation / metabolism*
  • Non-alcoholic Fatty Liver Disease / immunology*
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Signal Transduction / immunology*